Literature DB >> 8763344

How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein.

H J Broxterman1, J Lankelma, H M Pinedo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8763344     DOI： 10.1016/0959-8049(96)00045-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  11 in total

Review 1.  Diagnostics of multidrug resistance in cancer.

Authors:  G Szakács; K Jakab; F Antal; B Sarkadi
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

Review 2.  Classical multidrug resistance in acute myeloid leukaemia.

Authors:  E Paietta
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

3.  Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.

Authors:  S Song; M G Wientjes; Y Gan; J L Au
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 4.  Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

Authors:  Zhiwei Wang; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Dejuan Kong; Sanjeev Banerjee; Fazlul H Sarkar
Journal:  Drug Resist Updat       Date:  2010-08-09       Impact factor: 18.500

Review 5.  Flow cytometric evaluation of multidrug resistance proteins.

Authors:  Adorjan Aszalos; Barbara J Taylor
Journal:  Methods Mol Biol       Date:  2010

6.  Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines.

Authors:  M J Welters; A M Fichtinger-Schepman; R A Baan; M J Flens; R J Scheper; B J Braakhuis
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

7.  Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.

Authors:  M Lehnert; K Mross; J Schueller; B Thuerlimann; N Kroeger; H Kupper
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

8.  Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stain.

Authors:  H J Broxterman; G J Schuurhuis; J Lankelma; J W Oberink; C A Eekman; A M Claessen; K Hoekman; M Poot; H M Pinedo
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells.

Authors:  Lu Zhao; Yue Zhao; Bettina Schwarz; Josef Mysliwietz; Roland Hartig; Peter Camaj; Qi Bao; Karl-Walter Jauch; Makus Guba; Joachim Walter Ellwart; Peter Jon Nelson; Christiane Josephine Bruns
Journal:  Int J Oncol       Date:  2016-05-10       Impact factor: 5.650

10.  Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer.

Authors:  J Kreisholt; M Sorensen; P B Jensen; B S Nielsen; C B Andersen; M Sehested
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.